Found: 25
Select item for more details and to access through your institution.
Worse Wilms’ Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2024, v. 21, n. 5, p. 439, doi. 10.21873/cgp.20462
- By:
- Publication type:
- Article
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemia.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0790-5
- By:
- Publication type:
- Article
TCR CDR3‐antigen chemical complementarity associated with poor ovarian cancer outcomes: A vestigial immune response to early cancer antigens?
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 1, p. 1, doi. 10.1111/aji.13639
- By:
- Publication type:
- Article
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
- Published in:
- International Journal of Immunogenetics, 2021, v. 48, n. 5, p. 409, doi. 10.1111/iji.12550
- By:
- Publication type:
- Article
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 3, p. 697, doi. 10.1007/s11060-018-03001-1
- By:
- Publication type:
- Article
A scoring system for the electrostatic complementarities of T‐cell receptors and cancer‐mutant amino acids: multi‐cancer analyses of associated survival rates.
- Published in:
- Immunology, 2020, v. 159, n. 4, p. 373, doi. 10.1111/imm.13165
- By:
- Publication type:
- Article
Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 3, p. 345, doi. 10.1007/s11239-023-02909-4
- By:
- Publication type:
- Article
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 591, doi. 10.1007/s10549-020-05996-6
- By:
- Publication type:
- Article
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 1, p. 167, doi. 10.1007/s10549-018-4961-1
- By:
- Publication type:
- Article
Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 12047, doi. 10.1007/s00432-023-05059-5
- By:
- Publication type:
- Article
T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 3, p. 615, doi. 10.1007/s00432-018-2815-1
- By:
- Publication type:
- Article
Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.
- Published in:
- Biomedical Reports, 2022, v. 17, n. 2, p. N.PAG, doi. 10.3892/br.2022.1551
- By:
- Publication type:
- Article
High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitope.
- Published in:
- International Immunology, 2024, v. 36, n. 9, p. 465, doi. 10.1093/intimm/dxae025
- By:
- Publication type:
- Article
A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 3, p. 239, doi. 10.21873/cgp.20378
- By:
- Publication type:
- Article
TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease‐free survival.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 8, p. 1, doi. 10.1002/jmv.29043
- By:
- Publication type:
- Article
Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 4, p. 575, doi. 10.3390/biology12040575
- By:
- Publication type:
- Article
The presence of intratumoral Porphyromonas gingivalis correlates with a previously defined pancreatic adenocarcinoma, immune cell expression phenotype and with tumor resident, adaptive immune receptor features.
- Published in:
- Carcinogenesis, 2023, v. 44, n. 5, p. 411, doi. 10.1093/carcin/bgad033
- By:
- Publication type:
- Article
IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities.
- Published in:
- Biochemical Genetics, 2024, v. 62, n. 1, p. 530, doi. 10.1007/s10528-023-10437-2
- By:
- Publication type:
- Article
Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma.
- Published in:
- Journal of Molecular Neuroscience, 2022, v. 72, n. 9, p. 2011, doi. 10.1007/s12031-022-02050-6
- By:
- Publication type:
- Article
Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 5, p. 883, doi. 10.1111/ijlh.13862
- By:
- Publication type:
- Article
Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells.
- Published in:
- Journal of Molecular Neuroscience, 2021, v. 71, n. 11, p. 2393, doi. 10.1007/s12031-021-01813-x
- By:
- Publication type:
- Article
Matrix‐Metalloprotease Resistant Mucin‐16 (MUC16) Peptide Mutants Represent a Worse Lung Adenocarcinoma Outcome.
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 4, p. N.PAG, doi. 10.1002/prca.201800155
- By:
- Publication type:
- Article
MAPT (Tau) expression is a biomarker for an increased rate of survival for low-grade glioma.
- Published in:
- Oncology Reports, 2019, v. 41, n. 2, p. 1359
- By:
- Publication type:
- Article
Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.
- Published in:
- Cancer Informatics, 2023, p. 1, doi. 10.1177/11769351231177269
- By:
- Publication type:
- Article
Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.
- Published in:
- Cancer Informatics, 2023, v. 22, p. 1, doi. 10.1177/11769351231177269
- By:
- Publication type:
- Article